Legis Daily

Vietnam Veterans Liver Fluke Cancer Study Act

USA119th CongressHR-586| House 
| Updated: 4/8/2025
Nick LaLota

Nick LaLota

Republican Representative

New York

Cosponsors (8)
Marie Gluesenkamp Perez (Democratic)Patrick Ryan (Democratic)Donald G. Davis (Democratic)Josh Riley (Democratic)Brian K. Fitzpatrick (Republican)Juan Ciscomani (Republican)Josh Gottheimer (Democratic)Michael Lawler (Republican)

Health Subcommittee, Veterans' Affairs Committee, Veterans' Affairs Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This legislation mandates the Department of Veterans Affairs (VA) to initiate an epidemiological study within 120 days of enactment, in collaboration with the Centers for Disease Control and Prevention. The study will investigate the prevalence of cholangiocarcinoma , a rare liver cancer, among veterans who served in the Vietnam theater of operations during the Vietnam era, utilizing data from the VA Central Cancer Registry and the National Program of Cancer Registries. It aims to compare incidence rates in these veterans against the general U.S. population and identify percentages by various demographic characteristics such as age, gender, race, ethnicity, and geographic location at diagnosis. Following the study's completion, the VA must submit an initial report to Congress within one year, detailing the results and proposing administrative or legislative actions to address identified issues. The VA is also tasked with continuously tracking the prevalence of cholangiocarcinoma in these veterans and providing periodic follow-up reports to Congress with updated information. Separately, the bill includes a provision to amend title 38, United States Code, extending a certain limitation on pension payments from November 30, 2031, to December 31, 2031.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2568
Vietnam Veterans Liver Fluke Cancer Study Act

Bill from Previous Congress

HR 117-1273
Vietnam Veterans Liver Fluke Cancer Study Act

Bill from Previous Congress

HR 118-4424
Vietnam Veterans Liver Fluke Cancer Study Act
Jan 21, 2025
Introduced in House
Jan 21, 2025
Referred to the House Committee on Veterans' Affairs.
Feb 25, 2025
Referred to the Subcommittee on Health.
Apr 7, 2025
Mr. Bost moved to suspend the rules and pass the bill, as amended.
Apr 7, 2025
Considered under suspension of the rules. (consideration: CR H1435-1437)
Apr 7, 2025
DEBATE - The House proceeded with forty minutes of debate on H.R. 586.
Apr 7, 2025
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 7, 2025
Considered as unfinished business. (consideration: CR H1441-1442: 5)
Apr 7, 2025
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
View Vote
Apr 7, 2025
Motion to reconsider laid on the table Agreed to without objection.
Apr 8, 2025
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
  • Bill from Previous Congress

    HR 116-2568
    Vietnam Veterans Liver Fluke Cancer Study Act


  • Bill from Previous Congress

    HR 117-1273
    Vietnam Veterans Liver Fluke Cancer Study Act


  • Bill from Previous Congress

    HR 118-4424
    Vietnam Veterans Liver Fluke Cancer Study Act


  • January 21, 2025
    Introduced in House


  • January 21, 2025
    Referred to the House Committee on Veterans' Affairs.


  • February 25, 2025
    Referred to the Subcommittee on Health.


  • April 7, 2025
    Mr. Bost moved to suspend the rules and pass the bill, as amended.


  • April 7, 2025
    Considered under suspension of the rules. (consideration: CR H1435-1437)


  • April 7, 2025
    DEBATE - The House proceeded with forty minutes of debate on H.R. 586.


  • April 7, 2025
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • April 7, 2025
    Considered as unfinished business. (consideration: CR H1441-1442: 5)


  • April 7, 2025
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
    View Vote


  • April 7, 2025
    Motion to reconsider laid on the table Agreed to without objection.


  • April 8, 2025
    Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Armed Forces and National Security

AsiaCancerConflicts and warsCongressional oversightGovernment studies and investigationsHealth information and medical recordsMedical researchVeterans' medical careVietnam

Vietnam Veterans Liver Fluke Cancer Study Act

USA119th CongressHR-586| House 
| Updated: 4/8/2025
This legislation mandates the Department of Veterans Affairs (VA) to initiate an epidemiological study within 120 days of enactment, in collaboration with the Centers for Disease Control and Prevention. The study will investigate the prevalence of cholangiocarcinoma , a rare liver cancer, among veterans who served in the Vietnam theater of operations during the Vietnam era, utilizing data from the VA Central Cancer Registry and the National Program of Cancer Registries. It aims to compare incidence rates in these veterans against the general U.S. population and identify percentages by various demographic characteristics such as age, gender, race, ethnicity, and geographic location at diagnosis. Following the study's completion, the VA must submit an initial report to Congress within one year, detailing the results and proposing administrative or legislative actions to address identified issues. The VA is also tasked with continuously tracking the prevalence of cholangiocarcinoma in these veterans and providing periodic follow-up reports to Congress with updated information. Separately, the bill includes a provision to amend title 38, United States Code, extending a certain limitation on pension payments from November 30, 2031, to December 31, 2031.

Bill Text Versions

View Text
3 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-2568
Vietnam Veterans Liver Fluke Cancer Study Act

Bill from Previous Congress

HR 117-1273
Vietnam Veterans Liver Fluke Cancer Study Act

Bill from Previous Congress

HR 118-4424
Vietnam Veterans Liver Fluke Cancer Study Act
Jan 21, 2025
Introduced in House
Jan 21, 2025
Referred to the House Committee on Veterans' Affairs.
Feb 25, 2025
Referred to the Subcommittee on Health.
Apr 7, 2025
Mr. Bost moved to suspend the rules and pass the bill, as amended.
Apr 7, 2025
Considered under suspension of the rules. (consideration: CR H1435-1437)
Apr 7, 2025
DEBATE - The House proceeded with forty minutes of debate on H.R. 586.
Apr 7, 2025
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Apr 7, 2025
Considered as unfinished business. (consideration: CR H1441-1442: 5)
Apr 7, 2025
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
View Vote
Apr 7, 2025
Motion to reconsider laid on the table Agreed to without objection.
Apr 8, 2025
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
  • Bill from Previous Congress

    HR 116-2568
    Vietnam Veterans Liver Fluke Cancer Study Act


  • Bill from Previous Congress

    HR 117-1273
    Vietnam Veterans Liver Fluke Cancer Study Act


  • Bill from Previous Congress

    HR 118-4424
    Vietnam Veterans Liver Fluke Cancer Study Act


  • January 21, 2025
    Introduced in House


  • January 21, 2025
    Referred to the House Committee on Veterans' Affairs.


  • February 25, 2025
    Referred to the Subcommittee on Health.


  • April 7, 2025
    Mr. Bost moved to suspend the rules and pass the bill, as amended.


  • April 7, 2025
    Considered under suspension of the rules. (consideration: CR H1435-1437)


  • April 7, 2025
    DEBATE - The House proceeded with forty minutes of debate on H.R. 586.


  • April 7, 2025
    At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.


  • April 7, 2025
    Considered as unfinished business. (consideration: CR H1441-1442: 5)


  • April 7, 2025
    On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
    View Vote


  • April 7, 2025
    Motion to reconsider laid on the table Agreed to without objection.


  • April 8, 2025
    Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
Nick LaLota

Nick LaLota

Republican Representative

New York

Cosponsors (8)
Marie Gluesenkamp Perez (Democratic)Patrick Ryan (Democratic)Donald G. Davis (Democratic)Josh Riley (Democratic)Brian K. Fitzpatrick (Republican)Juan Ciscomani (Republican)Josh Gottheimer (Democratic)Michael Lawler (Republican)

Health Subcommittee, Veterans' Affairs Committee, Veterans' Affairs Committee

Armed Forces and National Security

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AsiaCancerConflicts and warsCongressional oversightGovernment studies and investigationsHealth information and medical recordsMedical researchVeterans' medical careVietnam